<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Merkel Cell Carcinoma - Disorder Mechanisms</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.2rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        .badge-mondo a {
            color: inherit;
            text-decoration: none;
        }

        .badge-mondo a:hover {
            text-decoration: underline;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .card-count {
            margin-left: auto;
            background: var(--bg);
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 0.8rem;
            color: var(--text-muted);
        }

        /* Sections */
        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-cell {
            background: #fce7f3;
            color: #9d174d;
        }

        .tag-gene {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-treatment {
            background: #ede9fe;
            color: #5b21b6;
        }

        .tag-env {
            background: #ccfbf1;
            color: #0f766e;
        }

        .tag-bio {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-modifier {
            background: #fee2e2;
            color: #991b1b;
            text-transform: uppercase;
            letter-spacing: 0.02em;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-classification {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-mechanistic {
            background: #dbeafe;
            color: #1e40af;
        }

        .linkout {
            color: inherit;
            margin-left: 6px;
            font-size: 0.75rem;
            text-decoration: none;
            border-bottom: 1px dotted rgba(0, 0, 0, 0.2);
        }

        .classification-category {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        /* Evidence styling */
        .evidence-toggle {
            cursor: pointer;
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 10px;
            user-select: none;
        }

        .evidence-toggle:hover {
            color: var(--primary);
        }

        .evidence-list {
            margin-top: 10px;
            padding-left: 0;
        }

        .evidence-item {
            padding: 12px 14px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .evidence-header {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 8px;
        }

        .evidence-ref {
            font-weight: 600;
            color: var(--secondary);
        }

        .evidence-ref a {
            color: inherit;
            text-decoration: none;
        }

        .evidence-ref a:hover {
            text-decoration: underline;
        }

        .evidence-support {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .support-SUPPORT { background: #dcfce7; color: #166534; }
        .support-PARTIAL { background: #fef3c7; color: #92400e; }
        .support-REFUTE { background: #fee2e2; color: #991b1b; }
        .support-NO_EVIDENCE { background: #f1f5f9; color: #64748b; }
        .support-WRONG_STATEMENT { background: #fecaca; color: #7f1d1d; }

        .evidence-source {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            background: #e2e8f0;
            color: #334155;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .evidence-support:hover,
        .evidence-source:hover {
            transform: translateY(-1px);
            box-shadow: 0 4px 10px rgba(0,0,0,0.08);
        }

        .source-HUMAN_CLINICAL { background: #e0f2fe; color: #075985; }
        .source-MODEL_ORGANISM { background: #fef9c3; color: #854d0e; }
        .source-IN_VITRO { background: #ede9fe; color: #5b21b6; }
        .source-COMPUTATIONAL { background: #cffafe; color: #0e7490; }
        .source-OTHER { background: #e5e7eb; color: #374151; }

        .evidence-snippet {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 8px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        .evidence-explanation {
            font-size: 0.85rem;
            color: var(--text);
            margin-top: 6px;
            line-height: 1.5;
        }

        .evidence-more {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 6px;
            font-style: italic;
        }

        /* Item containers with evidence */
        .item-box {
            padding: 16px;
            border-radius: 10px;
            margin-bottom: 12px;
        }

        .item-name {
            font-weight: 600;
            margin-bottom: 6px;
        }

        .item-desc {
            font-size: 0.9rem;
            line-height: 1.6;
            margin-bottom: 8px;
        }

        .item-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            margin-top: 8px;
        }

        /* Pathophysiology */
        .pathophys-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fef9c3 100%);
            border-left: 4px solid var(--accent-orange);
        }
        .pathophys-box .item-name { color: #92400e; }
        .pathophys-box .item-desc { color: #78350f; }

        /* Histopathology */
        .histopathology-box {
            background: #fff7ed;
            border-left: 4px solid #fb923c;
        }
        .histopathology-box .item-name { color: #9a3412; }
        .histopathology-box .item-desc { color: #c2410c; }

        .histopathology-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #ffedd5;
            color: #c2410c;
        }

        /* Phenotypes */
        .phenotype-box {
            background: #f0fdf4;
            border-left: 4px solid #22c55e;
        }
        .phenotype-box .item-name { color: #166534; }
        .phenotype-box .item-desc { color: #15803d; }

        .phenotype-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #dcfce7;
            color: #15803d;
        }

        .phenotype-category {
            font-size: 0.75rem;
            color: #4ade80;
        }

        .phenotype-id a {
            font-size: 0.8rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .phenotype-id a:hover {
            text-decoration: underline;
        }

        /* Genetic */
        .genetic-box {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
        }
        .genetic-box .item-name { color: #1e40af; }
        .genetic-box .item-desc { color: #2563eb; }

        /* Treatment */
        .treatment-box {
            background: #faf5ff;
            border-left: 4px solid #8b5cf6;
        }
        .treatment-box .item-name { color: #5b21b6; }
        .treatment-box .item-desc { color: #7c3aed; }

        /* Environmental */
        .environmental-box {
            background: #f0fdfa;
            border-left: 4px solid #14b8a6;
        }
        .environmental-box .item-name { color: #0f766e; }
        .environmental-box .item-desc { color: #0d9488; }

        /* Biochemical */
        .biochemical-box {
            background: #fffbeb;
            border-left: 4px solid #f59e0b;
        }
        .biochemical-box .item-name { color: #92400e; }
        .biochemical-box .item-desc { color: #b45309; }

        /* Differential Diagnoses */
        .differential-box {
            background: #fef2f2;
            border-left: 4px solid #dc2626;
        }
        .differential-box .item-name { color: #7f1d1d; }
        .differential-box .item-desc { color: #b91c1c; }

        .differential-similarities {
            background: #fee2e2;
            border-left: 2px solid #dc2626;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-distinctions {
            background: #dcfce7;
            border-left: 2px solid #16a34a;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-similarities strong,
        .differential-distinctions strong {
            display: block;
            margin-bottom: 6px;
            font-size: 0.85rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .differential-similarities ul,
        .differential-distinctions ul {
            margin-left: 16px;
            line-height: 1.6;
        }

        .differential-similarities li,
        .differential-distinctions li {
            margin: 4px 0;
            font-size: 0.9rem;
        }

        /* Datasets */
        .dataset-box {
            background: #f0f9ff;
            border-left: 4px solid #0284c7;
        }
        .dataset-box .item-name { color: #0c4a6e; }
        .dataset-box .item-desc { color: #0369a1; }

        .tag-dataset {
            background: #e0f2fe;
            color: #0369a1;
        }

        .tag-organism {
            background: #fae8ff;
            color: #a21caf;
        }

        .tag-datatype {
            background: #dbeafe;
            color: #1d4ed8;
        }

        /* Clinical Trials */
        .clinical-trial-box {
            background: #f5f3ff;
            border-left: 4px solid #a855f7;
        }
        .clinical-trial-box .item-name { color: #6b21a8; }
        .clinical-trial-box .item-desc { color: #7e22ce; }

        .tag-phase {
            background: #ede9fe;
            color: #6b21a8;
        }

        .tag-status {
            background: #fce7f3;
            color: #9d174d;
        }

        .trial-nct a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .trial-nct a:hover {
            text-decoration: underline;
        }

        .dataset-accession a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .dataset-accession a:hover {
            text-decoration: underline;
        }

        /* Subtypes */
        .subtype-box {
            background: #eef2ff;
            border-left: 4px solid var(--secondary);
        }
        .subtype-box .item-name { color: #3730a3; }
        .subtype-box .item-desc { color: #4f46e5; }

        /* Stats bar */
        .stats-bar {
            display: flex;
            gap: 24px;
            padding: 20px 24px;
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            margin-bottom: 24px;
            flex-wrap: wrap;
        }

        .stat-item {
            text-align: center;
        }

        .stat-value {
            font-size: 1.5rem;
            font-weight: 700;
            color: var(--primary);
        }

        .stat-label {
            font-size: 0.8rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* YAML preview */
        .yaml-preview {
            background: #1e293b;
            color: #e2e8f0;
            padding: 20px;
            border-radius: 8px;
            overflow-x: auto;
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            line-height: 1.5;
            max-height: 400px;
            overflow-y: auto;
        }

        .yaml-content {
            display: none;
        }

        .yaml-content.show {
            display: block;
        }

        /* Footer */
        .page-footer {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid var(--border);
            text-align: center;
            color: var(--text-muted);
            font-size: 0.85rem;
        }

        .page-footer a {
            color: var(--primary);
            text-decoration: none;
        }

        .page-footer a:hover {
            text-decoration: underline;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .page-header h1 { font-size: 1.6rem; }
            .stats-bar { gap: 16px; }
            .section-grid { grid-template-columns: 1fr; }
        }
        /* Mermaid graph */
        .mermaid-container {
            text-align: center;
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            border: 1px solid var(--border);
            overflow-x: auto;
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        .graph-warning {
            background: #fef3c7;
            border: 1px solid #f59e0b;
            border-radius: 8px;
            padding: 12px 16px;
            margin-bottom: 16px;
            font-size: 0.85rem;
            color: #92400e;
        }

        .graph-warning strong {
            display: block;
            margin-bottom: 4px;
        }

        .graph-warning ul {
            margin: 8px 0 0 20px;
            padding: 0;
        }

        .graph-warning li {
            margin: 4px 0;
        }
    </style>
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    

    

    
    

    

    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>Merkel Cell Carcinoma</span>
        </nav>

        <header class="page-header">
            <h1>Merkel Cell Carcinoma</h1>
            <div class="header-meta">
                
                
                <span class="badge badge-mondo">
                    <a href="http://purl.obolibrary.org/obo/MONDO_0019210" target="_blank">
                        MONDO:0019210
                    </a>
                </span>
                
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">skin carcinoma</span>
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">neuroendocrine carcinoma</span>
                
            </div>
            
            <p style="margin-top: 16px; font-size: 1rem; line-height: 1.6; opacity: 0.95; position: relative;">
                Merkel cell carcinoma (MCC) is a rare, aggressive neuroendocrine carcinoma of the skin arising from Merkel cells, specialized mechanoreceptor cells in the basal epidermis. MCC has two distinct etiologies: approximately 80% of cases are caused by clonal integration of Merkel cell polyomavirus (MCPyV) with expression of viral T antigens, while the remaining 20% are virus-negative and driven by UV-induced mutations resulting in high tumor mutational burden. MCC is highly aggressive with significant metastatic potential, but also immunogenic. Immune checkpoint inhibitors (avelumab, pembrolizumab) have transformed treatment of advanced MCC, with response rates of 50-70% and durable responses in many patients.
            </p>
            
        </header>

        <!-- Stats bar -->
        <div class="stats-bar">
            <div class="stat-item">
                <div class="stat-value">4</div>
                <div class="stat-label">Mechanisms</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">1</div>
                <div class="stat-label">Histopathology</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">2</div>
                <div class="stat-label">Phenotypes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">3</div>
                <div class="stat-label">Genes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">5</div>
                <div class="stat-label">Treatments</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">2</div>
                <div class="stat-label">Subtypes</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Differentials</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Datasets</div>
            </div>
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Trials</div>
            </div>
        </div>

        <!-- Classifications -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">üè∑</div>
                <h2 class="card-title">Classifications</h2>
            </div>
            
            <div style="margin-bottom: 16px;">
                <div class="classification-category">Harrison's Chapter</div>
                <div class="tag-list">
                    
                    <span class="tag tag-classification">cancer</span>
                    
                    <span class="tag tag-classification">solid tumor</span>
                    
                </div>
            </div>
            
            
            
            <div style="margin-bottom: 16px;">
                <div class="classification-category">ICD-O Morphology</div>
                <div class="tag-list">
                    <span class="tag tag-classification">Carcinoma</span>
                </div>
            </div>
            
            
            
            
        </div>
        

        <!-- Subtypes -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #eef2ff; color: #4f46e5;">‚óÜ</div>
                <h2 class="card-title">Subtypes</h2>
                <span class="card-count">2</span>
            </div>
            
            <div class="item-box subtype-box">
                <div class="item-name">MCPyV-Positive Merkel Cell Carcinoma</div>
                
                <div class="item-desc">Virus-driven MCC containing clonally integrated Merkel cell polyomavirus with expression of viral T antigens (small T and truncated large T antigens). Accounts for approximately 80% of MCC cases. Generally has lower tumor mutational burden than virus-negative MCC.</div>
                
                
    
    
            </div>
            
            <div class="item-box subtype-box">
                <div class="item-name">MCPyV-Negative Merkel Cell Carcinoma</div>
                
                <div class="item-desc">UV-induced MCC lacking viral integration. Characterized by high tumor mutational burden with UV signature mutations, including frequent RB1 inactivation. Accounts for approximately 20% of MCC cases.</div>
                
                
    
    
            </div>
            
        </div>
        

        <!-- Pathophysiology -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">‚öô</div>
                <h2 class="card-title">Pathophysiology</h2>
                <span class="card-count">4</span>
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Viral T Antigen Oncogenesis</div>
                
                <div class="item-desc">In MCPyV-positive MCC, clonally integrated virus expresses truncated large T antigen (LT) that binds and inactivates RB tumor suppressor protein, releasing E2F transcription factors and driving cell cycle progression. Small T antigen (sT) promotes proliferation through multiple mechanisms including 4E-BP1 hyperphosphorylation and cap-dependent translation.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Merkel cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000242" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        cell population proliferation
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0008283" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    <span class="tag tag-modifier">
        ‚Üë INCREASED
    </span>
    
    
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">RB1 Pathway Inactivation</div>
                
                <div class="item-desc">In virus-positive MCC, viral large T antigen binds and inactivates RB1 protein. In virus-negative MCC, RB1 is frequently inactivated by somatic mutations. In both cases, loss of RB1 function releases E2F transcription factors to drive cell cycle progression and proliferation.</div>
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        cell population proliferation
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0008283" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    <span class="tag tag-modifier">
        ‚Üë INCREASED
    </span>
    
    
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">UV-Induced Mutagenesis</div>
                
                <div class="item-desc">In virus-negative MCC (approximately 20%), high levels of UV-induced mutations (C&gt;T transitions at dipyrimidine sites) drive oncogenesis. These tumors have among the highest tumor mutational burdens of any cancer and frequently harbor mutations in TP53, RB1, and other tumor suppressors.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Merkel cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000242" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        cell population proliferation
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0008283" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    <span class="tag tag-modifier">
        ‚Üë INCREASED
    </span>
    
    
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Uncontrolled Merkel Cell Proliferation</div>
                
                <div class="item-desc">Whether driven by viral T antigens or UV-induced mutations, MCC cells exhibit uncontrolled proliferation. The neuroendocrine differentiation is retained, with expression of characteristic markers including CK20, chromogranin, and synaptophysin.</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        Merkel cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000242" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        cell population proliferation
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0008283" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    <span class="tag tag-modifier">
        ‚Üë INCREASED
    </span>
    
    
                    
                </div>
                
                
    
    
            </div>
            
        </div>
        

        <!-- Histopathology -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ffedd5; color: #c2410c;">‚ú∂</div>
                <h2 class="card-title">Histopathology</h2>
                <span class="card-count">1</span>
            </div>
            
            <div class="item-box histopathology-box">
                <div class="item-name">
                    Cutaneous Neuroendocrine Carcinoma
                    
                    <span class="histopathology-freq">VERY_FREQUENT</span>
                    
                </div>
                
                <div class="item-desc">Merkel carcinoma is a highly aggressive cutaneous neuroendocrine carcinoma.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/41232971" target="_blank">PMID:41232971</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Merkel&#39;s carcinoma is a rare but highly aggressive cutaneous neuroendocrine"</div>
                
                
                <div class="evidence-explanation">Abstract describes Merkel carcinoma as a highly aggressive cutaneous neuroendocrine tumor.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Causal Graph -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #e0e7ff; color: #4f46e5;">‚¨°</div>
                <h2 class="card-title">Causal Graph</h2>
            </div>
            
            <div class="mermaid-container">
                <pre class="mermaid">graph TD
    RB1_Pathway_Inactivation[&#34;RB1 Pathway Inactivation&#34;]
    Viral_T_Antigen_Oncogenesis[&#34;Viral T Antigen Oncogenesis&#34;]
    Uncontrolled_Merkel_Cell_Proliferation[&#34;Uncontrolled Merkel Cell Proliferation&#34;]

    Viral_T_Antigen_Oncogenesis --&gt; RB1_Pathway_Inactivation
    RB1_Pathway_Inactivation --&gt; Uncontrolled_Merkel_Cell_Proliferation

    style RB1_Pathway_Inactivation fill:#dbeafe
    style Viral_T_Antigen_Oncogenesis fill:#dbeafe
    style Uncontrolled_Merkel_Cell_Proliferation fill:#dbeafe</pre>
            </div>
        </div>
        

        <!-- Phenotypes -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #dcfce7; color: #16a34a;">‚óè</div>
                <h2 class="card-title">Phenotypes</h2>
                <span class="card-count">2</span>
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Neuroendocrine Neoplasm
                    
                    <span class="phenotype-freq">OBLIGATE</span>
                    
                    
                    <span class="phenotype-category">Dermatologic</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0100634" target="_blank">
                            HP:0100634
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    
            </div>
            
            <div class="item-box phenotype-box">
                <div class="item-name">
                    Cutaneous Nodule
                    
                    <span class="phenotype-freq">VERY_FREQUENT</span>
                    
                    
                    <span class="phenotype-category">Dermatologic</span>
                    
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/HP_0008069" target="_blank">
                            HP:0008069
                        </a>
                    </span>
                    
                </div>
                
                
                
    
    
            </div>
            
        </div>
        

        <!-- Genetic Associations -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #dbeafe; color: #2563eb;">üß¨</div>
                <h2 class="card-title">Genetic Associations</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    MCPyV T Antigens
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Viral Oncogenes)</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    RB1
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Somatic Mutations (in MCPyV-negative MCC))</span>
                    
                </div>
                
                
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    TP53
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Somatic Mutations (in MCPyV-negative MCC))</span>
                    
                </div>
                
                
    
    
            </div>
            
        </div>
        

        <!-- Treatments -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ede9fe; color: #7c3aed;">üíä</div>
                <h2 class="card-title">Treatments</h2>
                <span class="card-count">5</span>
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Avelumab
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Anti-PD-L1 antibody approved for metastatic MCC. First immune checkpoint inhibitor approved for MCC based on durable responses in the JAVELIN Merkel 200 trial. Response rates of approximately 30-35% in previously treated patients and higher in first-line setting.</div>
                
                
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Pembrolizumab
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Anti-PD-1 antibody approved for advanced MCC. Response rates of approximately 50-70% with durable responses. Both virus-positive and virus-negative MCC respond to checkpoint inhibition.</div>
                
                
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Surgical Excision
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000004" target="_blank">
                            MAXO:0000004
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Wide local excision with adequate margins (1-2 cm) is the primary treatment for localized MCC. Sentinel lymph node biopsy is recommended given high rate of occult nodal metastases.</div>
                
                
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Radiation Therapy
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000014" target="_blank">
                            MAXO:0000014
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">MCC is radiosensitive. Adjuvant radiation improves local control, particularly for tumors with high-risk features. Radiation may be used as primary treatment for unresectable tumors.</div>
                
                
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Chemotherapy
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000647" target="_blank">
                            MAXO:0000647
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">MCC is chemosensitive (like other small cell carcinomas) with initial response rates of 50-60% to platinum/etoposide regimens. However, responses are typically short-lived and chemotherapy has been largely supplanted by immunotherapy.</div>
                
                
    
    
            </div>
            
        </div>
        

        <!-- Environmental Factors -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ccfbf1; color: #0d9488;">üåç</div>
                <h2 class="card-title">Environmental Factors</h2>
                <span class="card-count">2</span>
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Ultraviolet Radiation</div>
                
                
                <div class="item-desc">UV exposure is a major risk factor for MCC. Most tumors occur on sun-exposed skin. UV signature mutations are characteristic of virus-negative MCC.</div>
                
                
    
    
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Immunosuppression</div>
                
                
                <div class="item-desc">Immunosuppression dramatically increases MCC risk (10-15 fold in organ transplant recipients). This suggests immune surveillance normally controls MCPyV-infected cells.</div>
                
                
    
    
            </div>
            
        </div>
        

        <!-- Biochemical Markers -->
        

        <!-- Differential Diagnoses -->
        

        <!-- Datasets -->
        

        <!-- Clinical Trials -->
        

        <!-- YAML Source -->
        <div class="card">
            <div class="card-header" style="cursor: pointer;" onclick="toggleYaml()">
                <div class="card-icon" style="background: #f1f5f9; color: #475569;">{ }</div>
                <h2 class="card-title">Source YAML</h2>
                <span class="card-count" id="yamlToggleText">click to show</span>
            </div>
            <div class="yaml-content" id="yamlContent">
                <pre class="yaml-preview">name: Merkel Cell Carcinoma
description: &gt;-
  Merkel cell carcinoma (MCC) is a rare, aggressive neuroendocrine carcinoma of the
  skin arising from Merkel cells, specialized mechanoreceptor cells in the basal
  epidermis. MCC has two distinct etiologies: approximately 80% of cases are caused
  by clonal integration of Merkel cell polyomavirus (MCPyV) with expression of viral
  T antigens, while the remaining 20% are virus-negative and driven by UV-induced
  mutations resulting in high tumor mutational burden. MCC is highly aggressive with
  significant metastatic potential, but also immunogenic. Immune checkpoint inhibitors
  (avelumab, pembrolizumab) have transformed treatment of advanced MCC, with response
  rates of 50-70% and durable responses in many patients.
categories:
- Skin Cancer
- Neuroendocrine Tumor
- Virus-Associated Cancer
parents:
- skin carcinoma
- neuroendocrine carcinoma
has_subtypes:
- name: MCPyV-Positive Merkel Cell Carcinoma
  description: &gt;-
    Virus-driven MCC containing clonally integrated Merkel cell polyomavirus
    with expression of viral T antigens (small T and truncated large T antigens).
    Accounts for approximately 80% of MCC cases. Generally has lower tumor
    mutational burden than virus-negative MCC.
- name: MCPyV-Negative Merkel Cell Carcinoma
  description: &gt;-
    UV-induced MCC lacking viral integration. Characterized by high tumor
    mutational burden with UV signature mutations, including frequent RB1
    inactivation. Accounts for approximately 20% of MCC cases.
infectious_agent:
- name: Merkel Cell Polyomavirus
  description: &gt;-
    MCPyV is a small DNA virus that clonally integrates into the host genome in
    approximately 80% of MCC cases. The virus expresses small T antigen (which
    promotes cell proliferation) and a truncated large T antigen (which retains
    RB1 binding but loses replication capacity). Viral T antigens drive
    tumorigenesis and are essential for tumor maintenance.
  evidence:
  - reference: PMID:41232971
    supports: SUPPORT
    snippet: &#34;Two subtypes have been identified: Merkel polyomavirus-related (MCPyV), present in 80% of cases in Europe, and
      UV-related.&#34;
    explanation: &#34;Supports the high prevalence of MCPyV-positive Merkel cell carcinoma.&#34;
  infectious_agent_term:
    preferred_term: Merkel cell polyomavirus
    term:
      id: NCBITaxon:493803
      label: Merkel cell polyomavirus
pathophysiology:
- name: Viral T Antigen Oncogenesis
  description: &gt;-
    In MCPyV-positive MCC, clonally integrated virus expresses truncated large
    T antigen (LT) that binds and inactivates RB tumor suppressor protein,
    releasing E2F transcription factors and driving cell cycle progression.
    Small T antigen (sT) promotes proliferation through multiple mechanisms
    including 4E-BP1 hyperphosphorylation and cap-dependent translation.
  cell_types:
  - preferred_term: Merkel cell
    term:
      id: CL:0000242
      label: Merkel cell
  biological_processes:
  - preferred_term: cell population proliferation
    modifier: INCREASED
    term:
      id: GO:0008283
      label: cell population proliferation
  locations:
  - preferred_term: skin of body
    term:
      id: UBERON:0002097
      label: skin of body
  downstream:
  - target: RB1 Pathway Inactivation
    description: Viral LT antigen sequesters and inactivates pRB protein
- name: RB1 Pathway Inactivation
  description: &gt;-
    In virus-positive MCC, viral large T antigen binds and inactivates RB1 protein.
    In virus-negative MCC, RB1 is frequently inactivated by somatic mutations.
    In both cases, loss of RB1 function releases E2F transcription factors to
    drive cell cycle progression and proliferation.
  biological_processes:
  - preferred_term: cell population proliferation
    modifier: INCREASED
    term:
      id: GO:0008283
      label: cell population proliferation
  downstream:
  - target: Uncontrolled Merkel Cell Proliferation
    description: E2F activation drives expression of cell cycle genes
- name: UV-Induced Mutagenesis
  description: &gt;-
    In virus-negative MCC (approximately 20%), high levels of UV-induced mutations
    (C&gt;T transitions at dipyrimidine sites) drive oncogenesis. These tumors have
    among the highest tumor mutational burdens of any cancer and frequently
    harbor mutations in TP53, RB1, and other tumor suppressors.
  cell_types:
  - preferred_term: Merkel cell
    term:
      id: CL:0000242
      label: Merkel cell
  biological_processes:
  - preferred_term: cell population proliferation
    modifier: INCREASED
    term:
      id: GO:0008283
      label: cell population proliferation
  locations:
  - preferred_term: skin of body
    term:
      id: UBERON:0002097
      label: skin of body
- name: Uncontrolled Merkel Cell Proliferation
  description: &gt;-
    Whether driven by viral T antigens or UV-induced mutations, MCC cells exhibit
    uncontrolled proliferation. The neuroendocrine differentiation is retained,
    with expression of characteristic markers including CK20, chromogranin,
    and synaptophysin.
  cell_types:
  - preferred_term: Merkel cell
    term:
      id: CL:0000242
      label: Merkel cell
  biological_processes:
  - preferred_term: cell population proliferation
    modifier: INCREASED
    term:
      id: GO:0008283
      label: cell population proliferation
histopathology:
- name: Cutaneous Neuroendocrine Carcinoma
  finding_term:
    preferred_term: Merkel Cell Carcinoma
    term:
      id: NCIT:C9231
      label: Merkel Cell Carcinoma
  frequency: VERY_FREQUENT
  description: Merkel carcinoma is a highly aggressive cutaneous neuroendocrine carcinoma.
  evidence:
  - reference: PMID:41232971
    supports: SUPPORT
    snippet: &#34;Merkel&#39;s carcinoma is a rare but highly aggressive cutaneous neuroendocrine&#34;
    explanation: Abstract describes Merkel carcinoma as a highly aggressive cutaneous neuroendocrine tumor.

phenotypes:
- category: Dermatologic
  name: Neuroendocrine Neoplasm
  frequency: OBLIGATE
  diagnostic: true
  description: &gt;-
    Merkel cell carcinoma is a high-grade neuroendocrine carcinoma with
    characteristic small round blue cell histology and neuroendocrine marker
    expression (synaptophysin, chromogranin, CD56).
  phenotype_term:
    preferred_term: Neuroendocrine neoplasm
    term:
      id: HP:0100634
      label: Neuroendocrine neoplasm
- category: Dermatologic
  name: Cutaneous Nodule
  frequency: VERY_FREQUENT
  diagnostic: true
  description: &gt;-
    Rapidly growing, firm, painless, dome-shaped nodule typically red or
    violaceous in color. Often described by AEIOU criteria: Asymptomatic,
    Expanding rapidly, Immunosuppression, Older age, UV-exposed site.
  phenotype_term:
    preferred_term: Neoplasm of the skin
    term:
      id: HP:0008069
      label: Neoplasm of the skin
environmental:
- name: Ultraviolet Radiation
  description: &gt;-
    UV exposure is a major risk factor for MCC. Most tumors occur on sun-exposed
    skin. UV signature mutations are characteristic of virus-negative MCC.
- name: Immunosuppression
  description: &gt;-
    Immunosuppression dramatically increases MCC risk (10-15 fold in organ
    transplant recipients). This suggests immune surveillance normally
    controls MCPyV-infected cells.
genetic:
- name: MCPyV T Antigens
  association: Viral Oncogenes
  notes: &gt;-
    In MCPyV-positive MCC, viral small T and truncated large T antigens are
    the primary oncogenic drivers. Large T antigen binds RB1, while small T
    antigen promotes proliferation through multiple mechanisms. Tumors are
    addicted to viral oncoprotein expression.
- name: RB1
  association: Somatic Mutations (in MCPyV-negative MCC)
  notes: &gt;-
    RB1 mutations occur in the majority of MCPyV-negative MCC but are
    virtually absent in virus-positive tumors, where viral LT antigen
    functionally inactivates RB1 protein.
- name: TP53
  association: Somatic Mutations (in MCPyV-negative MCC)
  notes: &gt;-
    TP53 mutations with UV signature are common in virus-negative MCC.
    Virus-positive tumors retain wild-type TP53, suggesting different
    selective pressures.
treatments:
- name: Avelumab
  description: &gt;-
    Anti-PD-L1 antibody approved for metastatic MCC. First immune checkpoint
    inhibitor approved for MCC based on durable responses in the JAVELIN Merkel
    200 trial. Response rates of approximately 30-35% in previously treated
    patients and higher in first-line setting.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
- name: Pembrolizumab
  description: &gt;-
    Anti-PD-1 antibody approved for advanced MCC. Response rates of approximately
    50-70% with durable responses. Both virus-positive and virus-negative MCC
    respond to checkpoint inhibition.
  treatment_term:
    preferred_term: pharmacotherapy
    term:
      id: MAXO:0000058
      label: pharmacotherapy
- name: Surgical Excision
  description: &gt;-
    Wide local excision with adequate margins (1-2 cm) is the primary treatment
    for localized MCC. Sentinel lymph node biopsy is recommended given high
    rate of occult nodal metastases.
  treatment_term:
    preferred_term: surgical procedure
    term:
      id: MAXO:0000004
      label: surgical procedure
- name: Radiation Therapy
  description: &gt;-
    MCC is radiosensitive. Adjuvant radiation improves local control,
    particularly for tumors with high-risk features. Radiation may be used
    as primary treatment for unresectable tumors.
  treatment_term:
    preferred_term: radiation therapy
    term:
      id: MAXO:0000014
      label: radiation therapy
- name: Chemotherapy
  description: &gt;-
    MCC is chemosensitive (like other small cell carcinomas) with initial
    response rates of 50-60% to platinum/etoposide regimens. However,
    responses are typically short-lived and chemotherapy has been largely
    supplanted by immunotherapy.
  treatment_term:
    preferred_term: chemotherapy
    term:
      id: MAXO:0000647
      label: chemotherapy
disease_term:
  preferred_term: Merkel cell carcinoma
  term:
    id: MONDO:0019210
    label: cutaneous neuroendocrine carcinoma
notes: &gt;-
  MCC is a paradigm for both viral oncogenesis and immunotherapy responsiveness.
  The dual etiology (viral versus UV-induced) highlights different mechanisms
  leading to the same tumor type. The high immunogenicity of MCC, whether due
  to viral antigens or high mutational burden, underlies the remarkable
  responses to checkpoint inhibitors. Viral T antigens represent potential
  targets for T-cell based therapies. The association with immunosuppression
  underscores the importance of immune surveillance in controlling this tumor.

classifications:
  icdo_morphology:
    classification_value: Carcinoma
  harrisons_chapter:
  - classification_value: cancer
  - classification_value: solid tumor
</pre>
            </div>
        </div>

        <footer class="page-footer">
            <p>
                Generated from <a href="https://github.com/monarch-initiative/dismech" target="_blank">dismech</a>
                knowledge base
            </p>
            <p style="margin-top: 8px;">
                <a href="https://github.com/monarch-initiative/dismech/blob/main/kb/disorders/Merkel_Cell_Carcinoma.yaml" target="_blank">View source on GitHub</a>
            </p>
        </footer>
    </div>

    <script>
        function toggleYaml() {
            const content = document.getElementById('yamlContent');
            const toggleText = document.getElementById('yamlToggleText');
            content.classList.toggle('show');
            toggleText.textContent = content.classList.contains('show') ? 'click to hide' : 'click to show';
        }
    </script>
</body>
</html>